Concomitant Tricuspid Annuloplasty in Patients Undergoing Totally Endoscopic Mitral Valve Surgery: A Propensity-Score Matched Analysis
DOI:
https://doi.org/10.1532/hsf.3675Keywords:
Totally endoscopic, Tricuspid annuloplasty, Tricuspid regurgitation, Minimally invasive, Mitral valve surgeryAbstract
Background: We aimed to evaluate the clinical outcomes of concomitant tricuspid annuloplasty (TAP) in patients undergoing totally endoscopic mitral valve surgery.
Methods: It is a single-center, retrospective study that enrolled a total of 173 patients who underwent mitral valve surgery combined with tricuspid annuloplasty between
January 2019 and June 2020 in our institution. Patients who underwent totally endoscopic mitral valve surgery with concomitant tricuspid annuloplasty were categorized into the MIMVS-TAP group (N = 51), and patients who underwent mitral valve surgery with concomitant tricuspid annuloplasty through a median sternotomy were categorized into the MVS-TAP group (N = 122). The data collected included detailed demographic and perioperative data. Each patient in the MIMVS-TAP group was individually matched to a patient in the MVS-TAP group, using the propensity scores, and we obtained a matched sample of 51 patients in each group. Parametric and nonparametric tests were used to analyze outcomes.
Results: There were no differences in death rates or related major adverse events between the two groups after propensity score matched analysis. The total operation time was longer in the MIMVS + TAP group versus the MVS+TAP group, as were the mean duration of cardiopulmonary bypass time and the cross-clamp time. The mean duration of intensive care unit stay was longer in the MVS + TAP group compared with that of the MIMVS + TAP group, as was the duration of post-operative hospital stay.
Conclusions: Totally endoscopic mitral valve surgery with concomitant tricuspid annuloplasty can improve a patient’s prognosis, with comparable short-term outcomes to those of the open approaches.
References
Akins CW, Miller DC, et al. 2008. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg. Apr; 85(4):1490-5.
Baumgartner H, Falk V, et al. 2017. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 38(36):2739–91.
Bianchi G, Solinas M, et al. 2009. Which patient undergoing mitral valve surgery should also have the tricuspid repair? Interact Cardiovasc Thorac Surg. Dec; 9(6):1009-20.
Bonaros N, Schachner T, et al. 2006. Robotically assisted totally endoscopic atrial septal defect repair: insights from operative times, learning curves, and clinical outcome. Ann Thorac Surg. Aug;82(2):687-93.
Calafiore AM, Gallina S, et al. 2009. Mitral valve surgery for functional mitral regurgitation: should moderate-or-more tricuspid regurgitation be treated? A propensity score analysis. Ann Thorac Surg. 87(3):698–703.
Carpentier A, Adams DH, Filsoufi F. 2010. Carpentier's Reconstructive Valve Surgery. Saunders Elsevier, Philadelphia, PA, pp. 194-200.
Chikwe J, Itagaki S, et al. 2015. Impact of concomitant tricuspid Annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse. J Am Coll Cardiol. 65(18):1931–8.
Cohen SR, Sell JE, et al. 1987. Tricuspid regurgitation in patients with acquired, chronic, pure mitral regurgitation. I. Prevalence, diagnosis, and comparison of preoperative clinical and hemodynamic features in patients with and without tricuspid regurgitation. J Thorac Cardiovasc Surg. Oct;94(4):481-7.
De Meester P, De Cock D, et al. 2015. Additional tricuspid annuloplasty in mitral valve surgery results in better clinical outcome. Heart. 101(9):720–6.
Di Mauro M, Bezante GP, et al. 2013. Italian Study Group on Valvular Heart Disease Italian Society of Cardiology. Functional tricuspid regurgitation: an underestimated issue. Int J Cardiol. Sep 30;168(2):707-15.
Dreyfus GD, Corbi PJ, et al. 2005. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg. Jan;79(1):127-32.
Gammie JS, Zhao Y, et al. 2010. J. Maxwell Chamberlain Memorial Paper for adult cardiac surgery. Less-invasive mitral valve operations: trends and outcomes from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. Nov;90(5):1401-8, 1410.e1; discussion 1408-10.
Grossi EA, LaPietra A, et al. 2001. Minimally invasive versus sternotomy approaches for mitral reconstruction: comparison of intermediate-term results. J Thorac Cardiovasc Surg. Apr;121(4):708-13.
Grossi EA, Loulmet DF, et al. 2012. Evolution of operative techniques and perfusion strategies for minimally invasive mitral valve repair. J Thorac Cardiovasc Surg. Apr;143(4 Suppl):S68-70.
Huang LC, Chen DZ, et al. 2020. Health-related quality of life following minimally invasive totally endoscopic mitral valve surgery. J Cardiothorac Surg. Jul 28;15(1):194.
Iribarne A, Easterwood R, et al. 2012. Comparative effectiveness of minimally invasive versus traditional sternotomy mitral valve surgery in elderly patients. J Thorac Cardiovasc Surg. Apr;143(4 Suppl):S86-90.
Izumi C, Iga K, Konishi T. 2002. Progression of isolated tricuspid regurgitation late after mitral valve surgery for rheumatic mitral valve disease. J Heart Valve Dis. May;11(3):353-6.
Kara I, Koksal C, et al. 2015. Outcomes of mild to moderate functional tricuspid regurgitation in patients undergoing mitral valve operations: a meta-analysis of 2,488 patients. Ann Thorac Surg. 100(6):2398–407.
King RM, Schaff HV, et al. 1984. Surgery for tricuspid regurgitation late after mitral valve replacement. Circulation. Sep;70(3 Pt 2):I193-7.
Lang RM, Bierig M, et al. 2005. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. Dec;18(12):1440-63.
Lucà F, van Garsse L, et al. 2013. Minimally invasive mitral valve surgery: a systematic review. Minim Invasive Surg. 179569.
Ma ZS, Dong MF, et al. 2011. Totally thoracoscopic repair of atrial septal defect without robotic assistance: a single-center experience. J Thorac Cardiovasc Surg. Jun;141(6):1380-3.
McCartney SL, Taylor BS, Nicoara A. 2019. Functional Tricuspid Regurgitation in Mitral Valve Disease. Semin Cardiothorac Vasc Anesth. Mar;23(1):108-122.
Modi P, Hassan A, Chitwood WR Jr. 2008. Minimally invasive mitral valve surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg. Nov;34(5):943-52.
Murzi M, Kallushi E, et al. 1997. Minimally Invasive Mitral Valve Repair Using Transthoracic Aortic Occlusion. Ann Thorac Surg. May;63(5):1477-9.
Nishimura RA, Otto CM, et al. 2014. 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. Jun 10;129(23):e521-643.
Pfannmueller B, Verevkin A, et al. 2013. Role of tricuspid valve repair for moderate tricuspid regurgitation during minimally invasive mitral valve surgery. Thorac Cardiovasc Surg. 61(5):386–91.
Quiñones MA, Otto CM, et al. 2002. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. Feb;15(2):167-84.
Ritwick B, Chaudhuri K, et al. 2013. Minimally invasive mitral valve procedures: the current state. Minim Invasive Surg. 679276.
Takano H, Hiramatsu M, et al. 2017. Severe tricuspid regurgitation after mitral valve surgery: the risk factors and results of the aggressive application of prophylactic tricuspid valve repair. Surg Today 47, 445–456.
Zoghbi WA, Enriquez-Sarano M, et al. 2003. American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. Jul;16(7):777-802.
Published
How to Cite
Issue
Section
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).